Vaccines to Prevent Infections by Oncoviruses

Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma

Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,608 · see citing works

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043 · cited 1× · see citing works

The causal relation between human papillomavirus and cervical cancer

Bosch, F. X., Lorincz, A. T., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,540 · see citing works

Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma

Feng, H., Shuda, M., Chang, Y., & Moore, P. S. (2008) · Science · doi:10.1126/science.1152586 · Cited by 3,208 · see citing works

The global health burden of infection‐associated cancers in the year 2002

Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932 · see citing works

HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS

Beasley, R. P., Lin, C., Hwang, L., & Chien, C. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,856 · see citing works

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,793 · see citing works

Global epidemiology of hepatitis C virus infection

Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758 · see citing works

Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., & Miyoshi, I. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6476 · Cited by 2,252 · see citing works

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Dürst, M., Gissmann, L., Ikenberg, H., & Hausen, H. Z. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3812 · Cited by 2,025 · see citing works

Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in Children

Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883 · see citing works

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,720 · see citing works

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women

Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655 · see citing works

Hepatitis B Virus Immunopathogenesis

Chisari, F. V., & Ferrari, C. I. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.000333 · Cited by 1,584 · see citing works

Epidemiology of Hepatocellular Carcinoma

Bosch, F. X., Ribes, J., Clèries, R., & Díaz, M. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.12.009 · Cited by 1,130 · see citing works

Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes

Bartosch, B., Dubuisson, J., & Cosset, F. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021756 · Cited by 1,111 · see citing works

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

Kirnbauer, R., Booy, F. P., Cheng, N., Lowy, D. R., & Schiller, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12180 · Cited by 1,107 · see citing works

Hepatitis B: The virus and disease #

Liang, J. T. (2009) · Hepatology · doi:10.1002/hep.22881 · Cited by 1,066 · see citing works

The epidemiology of human papillomavirus infections

Baseman, J. G., & Koutsky, L. A. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.12.008 · Cited by 955 · see citing works

Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia

Bosch, F. X., Burchell, A. N., SCHIFFMAN, M. H., Giuliano, A. R., de Sanjosé, S., Bruni, L., Tortolero‐Luna, G., Kjær, S. K., & Muñóz, N. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.064 · Cited by 841 · see citing works

Cancer risk in people infected with human immunodeficiency virus in the United States

Engels, E. A., Biggar, R. J., Hall, H. I., Cross, H., Crutchfield, A., Finch, J. L., Grigg, R., Hylton, T., Pawlish, K. S., McNeel, T. S., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23487 · Cited by 756 · see citing works

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

Goldstein, S. T., Zhou, F., Hadler, S. C., Bell, B. P., Mast, E. E., & Margolis, H. S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi206 · Cited by 743 · see citing works

Human hepatitis B vaccine from recombinant yeast

McAleer, W. J., Buynak, E. B., Maigetter, R. Z., Wampler, D. E., Miller, W. J. W., & Hilleman, M. R. (1984) · Nature · doi:10.1038/307178a0 · Cited by 740 · see citing works

Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B

Feinstone, S. M., Kapikian, A. Z., Purcell, R. H., Alter, H. J., & Holland, P. V. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504102921502 · Cited by 687 · see citing works

Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study

Chang, M., You, S., Chen, C., Liu, C., Lee, C., Lin, S., Chu, H.-C., Wu, T., Yang, S., Kuo, H., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp288 · Cited by 633 · see citing works

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

Brown, D. R., Kjær, S. K., Sigurðsson, K., Iversen, O., Hernández‐Ávila, M., Wheeler, C. M., Pérez, G., Koutsky, L. A., Tay, E. H., Garcia, P. J., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597307 · Cited by 629 · see citing works

Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon

Kato, T., Date, T., Miyamoto, M., Furusaka, A., Tokushige, K., Mizokami, M., & Wakita, T. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.023 · Cited by 589 · see citing works

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

Pestka, J. M., Zeisel, M. B., Bläser, E., Schürmann, P., Bartosch, B., Cosset, F., Patel, A. H., Meisel, H., Baumert, J. J., Viazov, S. O., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607026104 · Cited by 565 · see citing works

HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women

Gillison, M. L., Chaturvedi, A. K., & Lowy, D. R. (2008) · Cancer · doi:10.1002/cncr.23764 · Cited by 517 · see citing works

Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan

Roberts, J. N., Buck, C. B., Thompson, C. D., Kines, R. C., Bernardo, M., Choyke, P. L., Lowy, D. R., & Schiller, J. T. (2007) · Nature Medicine · doi:10.1038/nm1598 · Cited by 504 · see citing works

SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES

Kutok, J. L., & Wang, F. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100209 · Cited by 494 · see citing works

Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?

Stamatatos, L., Morris, L., Burton, D. R., & Mascola, J. R. (2009) · Nature Medicine · doi:10.1038/nm.1949 · Cited by 430 · see citing works

The influence of age on the development of the hepatitis B carrier state

Edmunds, W. J., Medley, G. F., Nokes, D. J., Hall, A. J., & Whittle, H. (1993) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1993.0102 · Cited by 425 · see citing works

Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults

Sokal, E. M., Hoppenbrouwers, K., Vandermeulen, C., Moutschen, M. P., Léonard, P., Moreels, A., Haumont, M., Bollen, A., Smets, F. N., & Denis, M. (2007) · The Journal of Infectious Diseases · doi:10.1086/523813 · Cited by 425 · see citing works

The global impact of vaccination against hepatitis B: A historical overview

Zanetti, A. R., Damme, P. V., & Shouval, D. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.056 · Cited by 422 · see citing works

Kaposi's Sarcoma-Associated Herpesvirus

Boshoff, C., & Weiss, R. A. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60739-3 · Cited by 398 · see citing works

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

Kjær, S. K., Sigurðsson, K., Iversen, O., Hernández‐Ávila, M., Wheeler, C. M., Pérez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., Garcia, P. J., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0031 · Cited by 333 · see citing works

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

Schiller, J. T., Castellsagué, X., Villa, L. L., & Hildesheim, A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.002 · Cited by 332 · see citing works

Flying Under the Radar: The Immunobiology of Hepatitis C

Dustin, L. B., & Rice, C. M. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141602 · Cited by 313 · see citing works

Prospects for a vaccine against the hepatitis C virus

Houghton, M., & Abrignani, S. (2005) · Nature · doi:10.1038/nature04081 · Cited by 312 · see citing works

The 4th nation‐wide study of adult T‐cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features

Tajima, K., The T‐ and B‐Cell Malignancy Study Group, & Co‐Authors (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450206 · Cited by 310 · see citing works

KSHV INFECTION AND THE PATHOGENESIS OF KAPOSI'S SARCOMA

Ganem, D. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100133 · Cited by 299 · see citing works

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

Strowig, T., Gurer, C., Ploß, A., Liu, Y., Arrey, F., Sashihara, J., Koo, G. C., Rice, C. M., Young, J. W., Chadburn, A., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20081720 · Cited by 296 · see citing works

The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding

Kines, R. C., Thompson, C. D., Lowy, D. R., Schiller, J. T., & Day, P. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908502106 · Cited by 292 · see citing works

Hepatitis B Vaccines

Pattyn, J., Hendrickx, G., Vorsters, A., & Damme, P. V. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa668 · Cited by 285 · see citing works

Hepatitis B virus-induced oncogenesis

Lupberger, J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i1.74 · Cited by 266 · see citing works

Treatment of solid organ transplant recipients with autologous Epstein Barr virus–specific cytotoxic T lymphocytes (CTLs)

Savoldo, B., Goss, J. A., Hammer, M. M., Zhang, L., Lopez, T., Gee, A. P., Lin, Y., Quirós‐Tejeira, R. E., Reinke, P., Schubert, S., et al. (2006) · Blood · doi:10.1182/blood-2006-05-021782 · Cited by 264 · see citing works

Early Experience with Human Papillomavirus Vaccine Introduction in the United States, Canada and Australia

Shefer, A. M., Markowitz, L. E., Deeks, S. L., Tam, T. W. S., Irwin, K. L., Garland, S. M., & Schuchat, A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.065 · Cited by 217 · see citing works

HIV/AIDS: Epidemiology, Pathophysiology, and Treatment of Kaposi Sarcoma–Associated Herpesvirus Disease: Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman Disease

Sullivan, R. J., Pantanowitz, L., Casper, C., Stebbing, J., & Dezube, B. J. (2008) · Clinical Infectious Diseases · doi:10.1086/592298 · Cited by 174 · see citing works

Hepatitis B virus variants

Chotiyaputta, W., & Lok, A. S.-F. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.107 · Cited by 169 · see citing works

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines

Jagu, S., Karanam, B., Gambhira, R., Chivukula, S. V., Chaganti, R. J., Lowy, D. R., Schiller, J. T., & Roden, R. B. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp106 · Cited by 165 · see citing works

Human papillomavirus infection and the primary and secondary prevention of cervical cancer

Lowy, D. R., Solomon, D., Hildesheim, A., Schiller, J. T., & Schiffman, M. (2008) · Cancer · doi:10.1002/cncr.23704 · Cited by 157 · see citing works

Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions

Klein, E., Kis, L. L., & Klein, G. (2007) · Oncogene · doi:10.1038/sj.onc.1210240 · Cited by 155 · see citing works

Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆

David, M., Herck, K. V., Hardt, K., Tibaldi, F. S., Dubin, G. O., Descamps, D., & Damme, P. V. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.01.011 · Cited by 152 · see citing works

Phase I Trial of a CD8+T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis

Elliott, S. L., Suhrbier, A., Miles, J. J., Lawrence, G., Pye, S. J., Le, T. T., Rosenstengel, A., Nguyen, T. H., Allworth, A. M., Burrows, S. R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01409-07 · Cited by 146 · see citing works

Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity

Zhang, P. C., Zhong, L., Struble, E. B., Watanabe, H., Kachko, A. V., Mihalik, K., Virata, M. L., Alter, H. J., Feinstone, S. M., & Major, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902749106 · Cited by 145 · see citing works

Cellular and molecular biology of HCV infection and hepatitis

Tang, H., & Grisé, H. (2009) · Clinical Science · doi:10.1042/cs20080631 · Cited by 134 · see citing works

Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma

Barillari, G., & Ensoli, B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.310-326.2002 · Cited by 119 · see citing works

Immunogenicity Testing in Human Papillomavirus Virus‐Like‐Particle Vaccine Trials

Schiller, J. T., & Lowy, D. R. (2009) · The Journal of Infectious Diseases · doi:10.1086/599988 · Cited by 117 · see citing works

Vaccine strategies against Epstein‐Barr virus‐associated diseases: lessons from studies on cytotoxic T‐cell‐mediated immune regulation

Khanna, R., Moss, D. J., & Burrows, S. R. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01328.x · Cited by 112 · see citing works

Immune escape by Epstein Barr virus associated malignancies

Münz, C., & Moormann, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.10.002 · Cited by 110 · see citing works

Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand

Poovorawan, Y., Chongsrisawat, V., Theamboonlers, A., Bock, H. L., Leyssen, M., & Jacquet, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.074 · Cited by 104 · see citing works

Primary Prevention of HTLV-I in Japan

Hino, S., Katamine, S., Miyata, H., Tsuji, Y., Yamabe, T., & Miyamoto, T. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199600001-00030 · Cited by 103 · see citing works

Transmission of human herpesvirus 8: an update

Pica, F., & Volpi, A. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3280143919 · Cited by 99 · see citing works

Development of hepatitis C virus vaccines: challenges and progress

Stoll‐Keller, F., Barth, H., Fafi‐Kremer, S., Zeisel, M. B., & Baumert, T. F. (2009) · Expert Review of Vaccines · doi:10.1586/14760584.8.3.333 · Cited by 96 · see citing works

Human T Cell Lymphotropic Virus (HTLV) Type–1–Specific CD8+T Cells: Frequency and Immunodominance Hierarchy

Goon, P. K. C., Biancardi, A., Fast, N. M., Igakura, T., Hanon, E., Mosley, A. J., Asquith, B., Gould, K. G., Marshall, S. E., Taylor, G. P., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/420832 · Cited by 88 · see citing works

Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus

Aresté, C., & Blackbourn, D. J. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.12.001 · Cited by 81 · see citing works

Primary prevention of HTLV-1 in Japan.

Hino, S., Katamine, S., Miyata, H., Tsuji, Y., Yamabe, T., & Miyamoto, T. (1997) · PubMed · Cited by 79 · see citing works

Recent advances in strategies for immunotherapy of human papillomavirus‐induced lesions

Kanodia, S., Silva, D. M. D., & Kast, W. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.23252 · Cited by 69 · see citing works

Mucosal Immunity and Protection Against HIV/SIV Infection: Strategies and Challenges for Vaccine Design

Demberg, T., & Robert-Guroff, M. (2009) · International Reviews of Immunology · doi:10.1080/08830180802684331 · Cited by 69 · see citing works

Salmonella enterica Serovar Typhi Ty21a Expressing Human Papillomavirus Type 16 L1 as a Potential Live Vaccine against Cervical Cancer and Typhoid Fever

Fraillery, D., Baud, D., Pang, S., Schiller, J. T., Bobst, M., Zosso, N., Ponci, F., & Nardelli‐Haefliger, D. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00164-07 · Cited by 68 · see citing works

Transfusion‐associated hepatitis not due to viral hepatitis type A or B†

Feinstone, S. M., Kapikian, A. Z., Purcell, R. H., Alter, H. J., Holland, P. V., & Zuckerman, R. B. A. J. (2001) · Reviews in Medical Virology · doi:10.1002/rmv.304 · Cited by 57 · see citing works

The current state of introduction of HPV vaccination into national immunisation schedules in Europe: Results of the VENICE 2008 survey

Lévy-Bruhl, D., Bousquet, V., King, L. A., O’Flanagan, D., Bacci, S., Lopalco, P. L., & Salmaso, S. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.023 · Cited by 51 · see citing works

Tumor immunity against adult T‐cell leukemia

Kannagi, M., Harashima, N., Kurihara, K., Ohashi, T., Utsunomiya, A., Tanosaki, R., Masuda, M., Tomonaga, M., & Okamura, J. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00050.x · Cited by 47 · see citing works

Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma

Cantarella, G., Liniger, M., Zúñiga, A., Schiller, J. T., Billeter, M., Naim, H. Y., & Glueck, R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.061 · Cited by 46 · see citing works

Targeted Therapy for Kaposi Sarcoma

Sullivan, R. J., Pantanowitz, L., & Dezube, B. J. (2009) · BioDrugs · doi:10.2165/00063030-200923020-00001 · Cited by 43 · see citing works

Standardized and Highly Efficient Expansion of Epstein-Barr Virus-Specific CD4 + T Cells by Using Virus-Like Particles

Adhikary, D., Behrends, U., Feederle, R., Delecluse, H., & Mautner, J. (2008) · Journal of Virology · doi:10.1128/jvi.02227-07 · Cited by 39 · see citing works

PASSIVE IMMUNIZATION AGAINST HEPATITIS B: A REVIEW OF RECENT STUDIES AND COMMENT ON CURRENT ASPECTS OF CONTROL

Maynard, J. E. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112520 · Cited by 32 · see citing works

Induction of Protective Immunity against Murine Gammaherpesvirus 68 Infection in the Absence of Viral Latency

Jia, Q., Freeman, M. L., Yager, E. J., McHardy, I. H., Tong, L. M., Martinez-Guzman, D., Rickabaugh, T. M., Hwang, S., Blackman, M. A., Sun, R., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01543-09 · Cited by 30 · see citing works

Epstein-Barr virus vaccine development: a lytic and latent protein cocktail

Timothy, D. L. (2008) · Frontiers in bioscience · doi:10.2741/3126 · Cited by 29 · see citing works

Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhadinoviruses.

Westmoreland, S. V., & Mansfield, K. G. (2008) · PubMed · Cited by 27 · see citing works

Advances in HTLV-1 Peptide Vaccines and Therapeutics

Lynch, M., & Kaumaya, P. T. P. (2006) · Current Protein and Peptide Science · doi:10.2174/138920306776359803 · Cited by 23 · see citing works

Protective Efficacy of Multiepitope Human Leukocyte Antigen???A*0201 Restricted Cytotoxic T-Lymphocyte Peptide Construct Against Challenge With Human T-Cell Lymphotropic Virus Type 1 Tax Recombinant Vaccinia Virus

Sundaram, R., Lynch, M. P., Rawale, S. V., Dakappagari, N. K., Young, D. C., Walker, C. M., Lemonnier, F. A., Jacobson, S., & Kaumaya, P. T. P. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200411010-00001 · Cited by 20 · see citing works

Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus

Delecluse, H., Feederle, R., Behrends, U., & Mautner, J. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.09.001 · Cited by 14 · see citing works

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,970 · see citing works

Human Viral Oncogenesis: A Cancer Hallmarks Analysis

Mesri, E. A., Feitelson, M. A., & Münger, K. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.011 · Cited by 646 · see citing works

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma

Llovet, J. M., Pinyol, R., Yarchoan, M., Singal, A. G., Marron, T. U., Schwartz, M., Pikarsky, E., Kudo, M., & Finn, R. S. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00868-0 · Cited by 391 · see citing works

T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance

Chandran, S. S., & Klebanoff, C. A. (2019) · Immunological Reviews · doi:10.1111/imr.12772 · Cited by 325 · see citing works

The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches

Pandya, P. H., Murray, M. E., Pollok, K. E., & Renbarger, J. L. (2016) · Journal of Immunology Research · doi:10.1155/2016/4273943 · Cited by 260 · see citing works

Future directions in cancer prevention

Umar, A., Dunn, B. K., & Greenwald, P. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3397 · Cited by 251 · see citing works

Reducing HPV-Associated Cancer Globally

Lowy, D. R., & Schiller, J. T. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0542 · Cited by 236 · see citing works

Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T‐cell activation

Rosalia, R. A., Quakkelaar, E. D., Redeker, A., Khan, S., Camps, M. G. M., Drijfhout, J. W., Silva, A. L., Jiskoot, W., van Hall, T., van Veelen, P. A., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201343324 · Cited by 217 · see citing works

Enhancing in situ cancer vaccines using delivery technologies

Gong, N., Alameh, M., El-Mayta, R. D., Xue, L., Weissman, D., & Mitchell, M. J. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00974-9 · Cited by 187 · see citing works

T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome

Klebanoff, C. A., Chandran, S. S., Baker, B. M., Quezada, S. A., & Ribas, A. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00809-z · Cited by 158 · see citing works

Immune modulation during latent herpesvirus infection

White, D. W., Beard, R. S., & Barton, E. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01074.x · Cited by 155 · see citing works

An Introduction to Virus Infections and Human Cancer

Schiller, J. T., & Lowy, D. R. (2020) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-57362-1_1 · Cited by 150 · see citing works

Immunotherapy against cancer-related viruses

Tashiro, H., & Brenner, M. K. (2016) · Cell Research · doi:10.1038/cr.2016.153 · Cited by 143 · see citing works

The gut microbiota in cancer immunity and immunotherapy

Xie, M., Li, X., Lau, H. C.-H., & Yu, J. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01326-2 · Cited by 125 · see citing works

Kaposi's Sarcoma Herpesvirus MicroRNAs Induce Metabolic Transformation of Infected Cells

Yogev, O., Lagos, D., Enver, T., & Boshoff, C. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004400 · Cited by 120 · see citing works

Mechanisms linking pathogens-associated inflammation and cancer

Porta, C., Riboldi, E., & Sica, A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.012 · Cited by 119 · see citing works

Neutralization Serotyping of BK Polyomavirus Infection in Kidney Transplant Recipients

Pastrana, D. V., Brennan, D. C., Çuburu, N., Storch, G. A., Viscidi, R. P., Randhawa, P. S., & Buck, C. B. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002650 · Cited by 109 · see citing works

The prevention of infection-associated cancers

Flora, S. D., & Bonanni, P. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr054 · Cited by 98 · see citing works

Virus Infection and Human Cancer: An Overview

Schiller, J. T., & Lowy, D. R. (2013) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-38965-8_1 · Cited by 92 · see citing works

Topical immunization strategies

Czerkinsky, C. C., & Holmgren, J. R. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.55 · Cited by 88 · see citing works

Colorectal cancer prevention: Immune modulation taking the stage

Fletcher, R., Wang, Y., Schoen, R. E., Finn, O. J., Yu, J., & Zhang, L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.12.002 · Cited by 77 · see citing works

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines

Tornesello, A. L., Tagliamonte, M., Buonaguro, F. M., Tornesello, M. L., & Buonaguro, L. (2022) · Vaccines · doi:10.3390/vaccines10020227 · Cited by 76 · see citing works

A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice

Ogembo, J. G., Muraswki, M. R., McGinnes, L. W., Parcharidou, A., Sutiwisesak, R., Tison, T., Avendano, J., Agnani, D., Finberg, R. W., Morrison, T. G., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0415-2 · Cited by 76 · see citing works

High-Throughput Pseudovirion-Based Neutralization Assay for Analysis of Natural and Vaccine-Induced Antibodies against Human Papillomaviruses

Sehr, P. A., Rubio, I., Seitz, H., Putzker, K., Ribeiro-Müller, L., Pawlita, M., & Müller, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075677 · Cited by 71 · see citing works

Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches

Mahdevar, E., Safavi, A., Abiri, A., Kefayat, A., Hejazi, S. H., Miresmaeili, S. M., & Mobarakeh, V. I. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1883111 · Cited by 69 · see citing works

Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera

Draper, E., Bissett, S. L., Howell‐Jones, R., Edwards, D., Munslow, G., Soldan, K., & Beddows, S. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.021 · Cited by 59 · see citing works

Multiple Infections and Cancer: Implications in Epidemiology

Vedham, V., Divi, R. L., Starks, V. L., & Verma, M. (2013) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500366 · Cited by 56 · see citing works

Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice

Perez, E. M., Foley, J., Tison, T., Silva, R., & Ogembo, J. G. (2016) · Oncotarget · doi:10.18632/oncotarget.13770 · Cited by 56 · see citing works

Breaking Bottlenecks for the TCR Therapy of Cancer

Gaissmaier, L., Elshiaty, M., & Christopoulos, P. (2020) · Cells · doi:10.3390/cells9092095 · Cited by 52 · see citing works

Interplay between viruses and bacterial microbiota in cancer development

Vyshenska, D., Lam, K. C., Shulzhenko, N., & Morgun, A. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.05.003 · Cited by 49 · see citing works

Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy

Mohite, P. B., Yadav, V., Pandhare, R., Maitra, S., Saleh, F. M., Saleem, R. M., Al-malky, H. S., Kumarasamy, V., Subramaniyan, V., Abdel‐Daim, M. M., et al. (2024) · ACS Omega · doi:10.1021/acsomega.3c06501 · Cited by 47 · see citing works

Prophylactic and therapeutic vaccine development: advancements and challenges

Weerarathna, I. N., Doelakeh, E. S., Kiwanuka, L., Kumar, P., & Arora, S. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00222-x · Cited by 43 · see citing works

Systemic and Mucosal Immune Responses to Sublingual or Intramuscular Human Papilloma Virus Antigens in Healthy Female Volunteers

Huo, Z., Bissett, S. L., Giemza, R., Beddows, S. A., Oeser, C., & Lewis, D. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033736 · Cited by 43 · see citing works

Role of Viral Infections in Testicular Cancer Etiology: Evidence From a Systematic Review and Meta-Analysis

Garolla, A., Vitagliano, A., Muscianisi, F., Valente, U., Ghezzi, M., Andrisani, A., Ambrosini, G., & Foresta, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00355 · Cited by 43 · see citing works

Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines

Hargrave, A., Mustafa, A. S., Hanif, A., Tunio, J. H., & Hanif, S. N. M. (2023) · Vaccines · doi:10.3390/vaccines11111633 · Cited by 38 · see citing works

Anti-cancer vaccines - a one-hit wonder?

Liu, J. K. H. (2014) · Europe PMC (PubMed Central) · Cited by 38 · see citing works

Stress Responses of Bacterial Cells as Mechanism of Development of Antibiotic Tolerance (Review)

Ткаченко, А. Г. (2018) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683818020114 · Cited by 38 · see citing works

Experience with Synthetic Vaccines for Cancer and Persistent Virus Infections in Nonhuman Primates and Patients

Quakkelaar, E. D., & Melief, C. J. M. (2012) · Advances in immunology · doi:10.1016/b978-0-12-396548-6.00004-4 · Cited by 38 · see citing works

Antiviral Activity of Fnc, 2′-Deoxy-2′-β-Fluoro-4′-Azidocytidine, against Human and Duck HBV Replication

Zheng, L., Wang, Q., Yang, X., Guo, X., Chen, L., Tao, L., Dong, L., Li, Y., An, H., Yu, X., et al. (2012) · Antiviral Therapy · doi:10.3851/imp2094 · Cited by 37 · see citing works

DNAzymes, Novel Therapeutic Agents in Cancer Therapy: A Review of Concepts to Applications

Thomas, I. B. K., Gaminda, K. A. P., Jayasinghe, C. D., Abeysinghe, T., & Senthilnithy, R. (2021) · Journal of Nucleic Acids · doi:10.1155/2021/9365081 · Cited by 34 · see citing works

Immunizing against Anogenital Cancer: HPV Vaccines

Pogoda, C. S., Roden, R. B. S., & Garcea, R. L. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005587 · Cited by 33 · see citing works

Sensitive Detection of Viral Transcripts in Human Tumor Transcriptomes

Schelhorn, S.-E., Fischer, M., Toloşi, L., Altmüller, J., Nürnberg, P., Pfister, H., Lengauer, T., & Berthold, F. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003228 · Cited by 32 · see citing works

Current and Potential Treatments for Ubiquitous but Neglected Herpesvirus Infections

Gable, J. E., Acker, T. M., & Craik, C. S. (2014) · Chemical Reviews · doi:10.1021/cr500255e · Cited by 29 · see citing works

Influence of Oxidation and Multimerization on the Immunogenicity of a Thioredoxin-L2 Prophylactic Papillomavirus Vaccine

Seitz, H., Dantheny, T., Burkart, F., Ottonello, S., & Müller, M. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00195-13 · Cited by 28 · see citing works

Vaccination against sexually transmitted infections

Fairley, C. K., & Read, T. R. H. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834e9aeb · Cited by 27 · see citing works

Emerging topics in human tumor virology

Hoppe‐Seyler, F., & Hoppe‐Seyler, K. (2011) · International Journal of Cancer · doi:10.1002/ijc.26087 · Cited by 25 · see citing works

Ecological and Evolutionary Consequences of Anticancer Adaptations

Boutry, J., Dujon, A. M., Gérard, A., Tissot, S., MacDonald, N., Schultz, A. G., Biro, P. A., Beckmann, C., Hamede, R., Hamilton, D. G., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101716 · Cited by 25 · see citing works

Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2

Seitz, H., Schmitt, M., Böhmer, G., Kopp‐Schneider, A., & Müller, M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27831 · Cited by 24 · see citing works

Advances in therapeutic cancer vaccines: Harnessing immune adjuvants for enhanced efficacy and future perspectives

Ren, D., Xiong, S., Ren, Y., Yang, X., Zhao, X., Jin, J., Xu, M., Liang, T., Guo, L., & Weng, L. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.04.054 · Cited by 23 · see citing works

Antiviral Activity of Various 1-(2′-Deoxy-β- d -lyxofuranosyl), 1-(2′-Fluoro-β- d -xylofuranosyl), 1-(3′-Fluoro-β- d -arabinofuranosyl), and 2′-Fluoro-2′,3′-didehydro-2′,3′-dideoxyribose Pyrimidine Nucleoside Analogues against Duck Hepatitis B Virus (DHBV) and Human Hepatitis B Virus (HBV) Replication

Srivastav, N. C., Shakya, N., Mak, M., Agrawal, B., Tyrrell, D. L., & Kumar, R. K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100803c · Cited by 23 · see citing works

Viral Infections: Negative Regulators of Apoptosis and Oncogenic Factors

Zamaraev, A. V., Zhivotovsky, B., & Kopeina, G. S. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920100077 · Cited by 21 · see citing works

Human Papillomavirus Antibody Reference Reagents for Use in Postvaccination Surveillance Serology

Bissett, S. L., Wilkinson, D. E., Tettmar, K. I., Jones, N., Stanford, E., Panicker, G., Faust, H., Borrow, R., Soldan, K., Unger, E. R., et al. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05641-11 · Cited by 20 · see citing works

Cancer Prevention: Lessons Learned and Future Directions

Dunn, B. K., & Kramer, B. S. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.11.003 · Cited by 20 · see citing works

Boosting Antitumor Immunity with an Expanded Neoepitope Landscape

Nagel, R., Pataskar, A., Champagne, J., & Agami, R. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1525 · Cited by 19 · see citing works

Tumour Immunotherapy and Applications of Immunological Products: A Review of Literature

Oli, A. N., Adejumo, S. A., Rowaiye, A. B., Ogidigo, J. O., Hampton‐Marcell, J., & Ibeanu, G. C. (2024) · Journal of Immunology Research · doi:10.1155/2024/8481761 · Cited by 16 · see citing works

Polymeric Display of Proteins through High Affinity Leucine Zipper Peptide Adaptors

Craig, P. O., Alzogaray, V., & Goldbaum, F. A. (2012) · Biomacromolecules · doi:10.1021/bm201875p · Cited by 16 · see citing works

E6AP goes viral: the role of E6AP in viral- and non-viral-related cancers

Bandilovska, I., Keam, S. P., Gamell, C., Machicado, C., Haupt, S., & Haupt, Y. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz072 · Cited by 16 · see citing works

Baculovirus expression systems for production of recombinant proteins in insect and mammalian cells

Beljelarskaya, S. N. (2011) · Molecular Biology · doi:10.1134/s002689331101002x · Cited by 16 · see citing works

Viral infections and human cancers: the legacy of Denis Burkitt

Harford, J. B. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09017.x · Cited by 14 · see citing works

Prevention and Treatment for Epstein–Barr Virus Infection and Related Cancers

Smets, F. N., & Sokal, E. M. (2013) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-38965-8_10 · Cited by 14 · see citing works

The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses

Gilani, U. S., Shaukat, M., Rasheed, A., Shahid, M., Tasneem, F., Arshad, M. I., Rashid, N., & Shahzad, N. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25292 · Cited by 13 · see citing works

Beyond Viral Infections: The Multifaceted Roles of Human Papillomavirus and Epstein-Barr Virus in Shaping the Tumor Microenvironment

Fernandes, Q., Sher, G., Prabhu, K. S., Kuttikrishnan, S., Merhi, M., Dermime, S., Junejo, K., Bhat, A. A., & Shahab Uddin, M. S. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436180.1 · Cited by 12 · see citing works

Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunity

Bot, A. I., Qiu, Z., Wong, R. M. H., Obrocea, M., & Smith, K. A. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-132 · Cited by 12 · see citing works

Can HPV vaccination help to prevent anal cancer?

Palefsky, J. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70226-7 · Cited by 12 · see citing works

The new sexual politics of cancer: Oncoviruses, disease prevention, and sexual health promotion

Mamo, L., & Epstein, S. (2016) · BioSocieties · doi:10.1057/biosoc.2016.10 · Cited by 11 · see citing works

Avian Models for Human Carcinogenesis—Recent Findings from Molecular and Clinical Research

Niebora, J., Data, K., Domagała, D., Józkowiak, M., Barrett, S., Abbariki, T. N., Bryja, A., Kulus, M., Woźniak, S., Ziemak, H., et al. (2024) · Cells · doi:10.3390/cells13211797 · Cited by 9 · see citing works

Mining for viral fragments in methylation enriched sequencing data

Mensaert, K., Criekinge, W. V., Thas, O., Schuuring, E. M. D., Steenbergen, R. D. M., Wisman, G. B. A., & Meyer, T. D. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00016 · Cited by 8 · see citing works

Immune Control and Vaccination against the Epstein–Barr Virus in Humanized Mice

Münz, C. (2019) · Vaccines · doi:10.3390/vaccines7040217 · Cited by 8 · see citing works

Unveiling the nexus: The tumor microenvironment as a strategic frontier in viral cancers

Fernandes, Q., & Folorunsho, O. G. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156827 · Cited by 7 · see citing works

The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study

Punta, M., Jennings, V. A., Melcher, A. A., & Lise, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.524968 · Cited by 7 · see citing works

Oncogenic Viruses in Skull Base Chordomas

Yakkioui, Y., Speel, E. M., van Overbeeke, J. J., Boderie, M., Pujari, S., Hausen, A. Z., Wolffs, P. F. G., & Temel, Y. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.11.117 · Cited by 6 · see citing works

Recent advancements in the cancer vaccines: A review

Kawish, S. M., Hilles, A. R., Sharma, S., Alam, M., Alimujiang, K., Iqbal, Z., Beg, S., Mahmood, S., & Mirza, M. A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106422 · Cited by 3 · see citing works

Emerging Trends in Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: A Focus on Liver Transplant Candidates

Yu, D., Chen, H., & Wang, L. (2025) · Cancer Reports · doi:10.1002/cnr2.70244 · Cited by 2 · see citing works

Future directions and progress in cancer genetics

Khan, I. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33302-6.00008-1 · Cited by 2 · see citing works

The Immunomodulatory Roles of Extracellular Vesicles in the Pathogenesis of Virus-Related Cancers

Heidarzadeh-Asl, S., Kashanchi, F., & Jafari, R. (2026) · Viral Immunology · doi:10.1177/08828245251413728 · Cited by 1 · see citing works

Prevention and Early Detection of Cancer - A Public Health View

Majnarić, L. T., & Včev, A. (2012) · InTech eBooks · doi:10.5772/48042 · Cited by 1 · see citing works

Cancer Prevention II: Introduction

Dunn, B. K., & Greenwald, P. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.06.016 · Cited by 1 · see citing works

Therapeutic Approaches to Employ Monoclonal Antibody for Cancer Treatment

Martins, S., Salvi, P., Lavuri, S. T., Srivastava, M., Sakthivel, S., Barman, M. K., Chand, K., Singh, M., Sonkar, S. C., & Bhukya, P. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-6530-8.ch002 · Cited by 1 · see citing works

Immunity to Oncogenic Viruses

Münz, C., & Ploß, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00250-7 · Cited by 1 · see citing works

Chapter 21 – Vaccination to Treat Noninfectious Diseases: Surveying the Opportunities

Bachmann, M. F., & Vogel, M. (2006) · Academic Press eBooks · Cited by 1 · see citing works

Targeting Molecular Pathways for Prevention of High Risk Breast Cancer: A Model for Cancer Prevention

Showalter, S. L., & Brian, J. (2012) · InTech eBooks · doi:10.5772/31700 · Cited by 1 · see citing works

Miscellaneous Approaches and Considerations: TLR Agonists and Other Inflammatory Agents, Anti-Chemokine Agents, Infectious Agents, Tumor Stroma Targeting, Age and Sex Effects, and Miscellaneous Small Molecules

Svatek, R. S., & Curiel, T. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4732-0_13 · Cited by 1 · see citing works

Vaccination Against Breast Cancer and its Role in Prevention

Czerniecki, B. J., Nocera, N. F., Lowenfeld, L., Showalter, L., & Koski, G. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-27135-4_10 · Cited by 1 · see citing works

Hightech in der Infektiologie: Diagnose und Therapie

Bugert, J. J. (2012) · Springer eBooks · doi:10.1007/978-3-642-17158-1_4

Can HPV vaccination help to prevent anal cancer

Stahl, J. ‐., & Mailles, A. (2010)

Oral cancer with special reference to virus detection and quantitative gene expression

Jalouli, M. M. (2016)

Immunity to Oncogenic Viruses

Rickinson, A. B., Easom, N. J. W., Maini, M. K., & Rowe, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14025-1

Cancer Defenses in Humans and the Search for a Vaccine

Lu, Y. W. (2020) · Novel Approaches in Cancer Study · doi:10.31031/nacs.2020.05.000608

Hepatitis B core (HBc) virus like particle (VLP) as a platform for innovation of chimeric adjuvant-free VLP vaccines targeting oncoviruses

Zhang, B. (2021) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)

The role of Human Cytomegalovirus infection in Iraqi brain tumor patients

Amer, E. M., Alkhfaji, A. H. M. A., & .Hamad, Z. N. (2017) · Numerical Methods in Civil Engineering

Vaccination to Treat Noninfectious Diseases

Bachmann, M. F., & Vogel, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804019-5.00021-9

REVIEW

(2012) · Asia-Pacific Biotech News · doi:10.1142/s0219030312000043

From oncolytic virotherapy to individualized multimodal immunotherapy with focus on glioblastoma

Kampers, L. F. C., de Vliet, P. V., Schirrmacher, V., Gool, S. V., & Stücker, W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00020-5

Prospects of a Potential Vaccine for Kaposi’s Sarcoma-Associated Herpes Virus (KSHV)

Mani, M., Eshak, D., Arumugam, M., & Ponnuswamy, N. (2025) · Springer eBooks · doi:10.1007/978-3-031-77911-4_27

Molecular mastery: Harnessing DNA technology for disease prevention

Dornadula, G., Ramakrishna, C., Shaik, S. B., Meriga, P. K., Chintha, L., Gurugari, Y., D., K., Shaik, S. F., & Cheong, S. H. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101976

Role of Oncoviruses in Cancer Progression and Emerging Phytochemical-Based Therapies from Medicinal Plants

Singh, S., & Yadav, P. (2026) · Molecular Biotechnology · doi:10.1007/s12033-026-01561-6

Role of cancer vaccines in cancer immunotherapy

Kottarath, S. K., Singh, J., Pandey, A., & Srivastava, Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41551-7.00009-6

Applications of virus-like particles in therapeutics

Sharma, S., Pathan, H. K., Gupta, P. K., Mishra, M. K., & Sharma, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44119-6.00012-4

Immunological Determinants of Oncogenic Virus-Driven Cancers in Africa: Mechanisms, Co-Infections and Public Health Challenges

Aliyu, V. A., Akinsulie, O. C., Olowu, B. I., Idris, I., Ajibade, F. A., Babawale, P. I., Adebowale, O. O., Ugwu, C. E., Ukauwa, C. B., Itumo, O. E., et al. (2026) · Pathogens · doi:10.3390/pathogens15080800

FAIRsharing record for: Virus Particle Explorer

FAIRsharing Team, & McQuilton, P. (2022) · FAIRsharing.org · doi:10.25504/fairsharing.45e0f5

Immunotherapy of Oncovirus-Induced Cancers: A Review on the Development and Efficacy of Targeted Vaccines

Ng, C. S. (2025) · Vaccines · doi:10.3390/vaccines13090911 · Cited by 3 · see citing works

An Introduction to Virus Infections and Human Cancer

Schiller, J. T., & Lowy, D. R. (2020) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-57362-1_1 · Cited by 150 · see citing works

Virus Infection and Human Cancer: An Overview

Schiller, J. T., & Lowy, D. R. (2013) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-38965-8_1 · Cited by 92 · see citing works

Tumour virus vaccines: hepatitis B virus and human papillomavirus

Stanley, M. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0268 · Cited by 67 · see citing works

Viruses and human cancer

Vousden, K. H., & Farrell, P. J. (1994) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072910 · Cited by 33 · see citing works